Home >Newsletters >June 1997
 
ASA NEWSLETTER
 
 
June 1997
Volume 61
Number 6
 
PRACTICE MANAGEMENT

ASA Analyzes Commercial Relative Value System Based on Average Time

Karin Bierstein,
Practice Management Coordinator



In March, members received a letter from ASA President Phillip O. Bridenbaugh, M.D., alerting them to an alternative relative value system recently introduced by Cambridge Health Economics Group, Inc. (CHEG). Dr. Bridenbaugh wrote a second letter in May, describing briefly the results of our analysis of the CHEG product. This column will provide further details of those results and will also discuss negotiation strategy.

The CHEG "resource-based relative value scale" for anesthesia services, or ARBRVS™, incorporates average anesthesia times into a composite relative value for each anesthesia service. The ARBRVS™ relative values replace the base and time units of the ASA Relative Value Guide system. They are scaled to the Medicare RBRVS, so that a third-party payer can use the same dollar conversion factor for anesthesia as it does for surgical and medical procedures.

As noted in Dr. Bridenbaugh's letters, ASA contracted for an analysis of the ARBRVS™ by the Lewin Group, an independent consulting firm. Members of the ASA Task Force on Procedure-Based Reimbursement Systems reviewed the Lewin analysis. ASA leadership has long assumed that the winners and losers in any payment methodology based on national average times would depend on each practice's case mix and individual average times, and the Lewin analysis of the ARBRVS™ validates this assumption.

Structure of the ARBRVS™: The ARBRVS™ creates relative values for 254 anesthesia codes (the series of codes in the American Medical Association's Current Procedural Terminology Fourth Edition, or CPT-4, between 00100 and 01999) and also for 4,840 surgical codes. The basic algorithm used to compute the values is straightforward. CHEG obtained Medicare average time numbers from the "BMAD" data files maintained by the Health Care Financing Administration (HCFA), supplemented by commercial payer data from several unidentified midwestern health insurance carriers. Average time units were added to ASA RVG base units to yield average total billed units for each procedure. Multiplying the average total billed units by the Medicare anesthesia conversion factor yielded an average Medicare allowed charge for each anesthesia CPT code. To calibrate these values with respect to all other CPT codes in the Medicare Fee Schedule, average allowed charges were divided by the simple average of the three Medicare conversion factors for primary care, surgical and "other" services, i.e., $36.66.

To illustrate the formula, consider code 00406, "anesthesia for radical procedures on the breast with internal mammary node dissection," which has a base unit value of 13 and an average of 6.7 time units as estimated by CHEG:

13

base units

+

6.7


average time units

19.7

total units

x

$16.68


[1997 anesthesia conversion factor]

$328.60

Medicare average allowed charge, rounded
   

$328.60

÷

$36.66


[Nonanesthesia conversion factor]

8.96

CHEG units

 

How valid is this approach? CHEG has calculated an average Medicare payment for each anesthesia service and then calibrated that payment to the relative value units assigned to medical and surgical services by the Medicare RBRVS. The formula makes sense, if one wishes to use average rather than actual times. The results make less sense, however, because of the nature and quality of the average time information used by CHEG.

The Medicare files provide average times only for the 254 anesthesia codes. The midwestern carrier data define average times by surgical code. There is, in many instances, considerable variation between the two. When Lewin examined the 42 anesthesia codes that are crosswalked to a single surgical code, it found that use of a surgical code for a given procedure might result in more than double as many CHEG units as are assigned to the corresponding anesthesia code. There does not appear to be any justification for such anomalies.

Most of the anesthesia codes can be crosswalked to multiple surgical codes -- as many as 226 surgical codes -- in the case of 00100, "anesthesia for procedures on integumentary system of head and/or salivary glands." The minimum CHEG value for a surgical code corresponding to 00100 is 0.49 units and the maximum is 17.19, more than a 35-fold variation. Obviously, an anesthesiology group that bills using the anesthesia codes and whose case mix is weighted toward the low-end procedures is going to fare well under this system, while another group with a case mix favoring longer procedures is going to lose. As stated in the Lewin report, "At a minimum, if an average time system is implemented, the anesthesia coding system would have to be disaggregated to accommodate the significant differences in average times within the current anesthesia coding system."

ASA provided the Lewin Group with a database containing more than 83,000 commercial claims, with average times shown by surgical code. This database came from a billing company with a national anesthesia client base. Although the data do not represent a 100 percent or even a random sample, the degree of variation in average anesthesia times within surgical codes suggests that even if groups bill using surgical codes, whether an average time-based system will be lucrative or ruinous will depend on individual practice patterns.

What do "8.96 CHEG units" mean? The value assigned to a given procedure only acquires a monetary meaning when multiplied by a conversion factor (CF). If this CF is set high enough, reimbursement will be satisfactory. If the payer simply adopts the average Medicare CF of $36.66, reimbursement for 00406 will equal the average allowed charge of $328.60.

It is possible to determine a CF that will equalize reimbursement between the traditional base plus time units system and the ARBRVS™. The Lewin Group compared Medicare total units (adding 1995 BMAD average times to the base unit for each anesthesia code) to CHEG relative value units and concluded that the overall volume-weighted ratio was 2.18. Thus, an anesthesiology group with a commercial conversion factor of $40 (and with a practice exhibiting the same average times and same distribution of procedures as the HCFA national average distribution) would be held harmless under a conversion to the CHEG ARBRVS™ if the new conversion factor was $87.20 (2.18 x $40). Few, if any, anesthesia groups will in fact have the same distribution as the HCFA data, so the hold-harmless conversion factor of $87.20 should be considered illustrative only.

Negotiating the conversion factor. In an era when commercial anesthesia CFs tend to run between $30 and $50, very few payers will be likely to offer anything near $87.20. Nevertheless, in negotiations with a payer that is contemplating adoption of the CHEG ARBRVS™ along with a relatively low CF, it may be helpful to demonstrate the magnitude of the discount being suggested. Payers may simply be unaware of the difference. And, given that neither a payer nor an anesthesiology group can calculate the true impact of a changeover to the ARBRVS™ or any other average-time-based system without knowing the actual average times and case mixes for the group(s) affected, the payer will almost certainly not have budgeted the savings with any reasonable precision. But the payer should be able to tell you how much it proposes to pay for each procedure, and you should be able to compare that amount to your own averages.

Medicare undervalues anesthesia services. Many payers are attempting to adopt the Medicare Resource-Based Relative Value Scale (RBRVS) as a payment system for all specialties, and they typically offer physicians 110 to 130 percent of Medicare payment rates. Anesthesiologists confronting a contract with an unacceptable conversion factor that is based on the Medicare Fee Schedule may wish to show the carrier that anesthesia remains relatively undervalued by Medicare.

The 22.76-percent increase in the Medicare anesthesia work values that took effect on January 1, 1997, reflected a strategic compromise rather than the actual change needed for parity, in ASA's view. The multispecialty panel of experts convened in the first phase of the Abt Associates Inc. study of anesthesia work values recommended an increase of approximately 35 percent. The AMA/Specialty Society Relative Value Update Committee (RUC) invited ASA to attempt to validate this recommendation through a survey of double-boarded anesthesiologists. The result of the survey was a set of work values that were, on average, 30.3 percent higher than those contained in the report of the multispecialty panel.

Following this "validation," the original multispecialty panel reconvened to review its recommendation and the survey findings. In general, the panel concluded that the survey values were too high, but that the survey did warrant a modest adjustment to the panel's original recommendation, which went from a 35-percent to a 40-percent increase in work values.

ASA's final recommendation to the RUC in August 1996 was for a 35-percent increase. A redistribution of Medicare dollars, this being a budget-neutral exercise, of that magnitude was unpalatable to the other specialties on the RUC. Nevertheless, recognizing the merits of ASA's argument about undervaluation and of the Abt study methodology, the RUC voted unanimously to recommend a 22.76-percent increase to the Health Care Financing Administration (HCFA). In its final rule on the Medicare Fee Schedule for 1997, HCFA adopted that recommendation.

The 22.76-percent increase in work values was implemented through a 15.95-percent increase in the 1997 Medicare anesthesia conversion factor (CF). (Because of budget-neutrality adjustments that applied equally to all specialties, the final increase was 9.1 percent.) Had the multispecialty panel's and ASA's recommendations for a 35-percent increase been adopted, the adjustment to the CF would have been 24.29 percent. The difference between 24.29 and 15.95, i.e., 8.34 percentage points, arguably represents, at the least, Medicare's ongoing undervaluation of anesthesia services.

What more is ASA doing? We are exploring software and other tools that will allow an anesthesiologist to assess an alternative payment system such as CHEG's in relation to the practice's own average times and case mix. In the short term, if you would like a copy of the Lewin Group report (which, for licensing reasons, will not include the actual CHEG ARBRVS™ values), please contact the ASA Washington Office at (202) 289-2222; e-mail <mail@ASAwash.org>.

 


return to top


 


FEATURES

Litigation v. Liability: Striking a Balance

ARTICLES


DEPARTMENTS


The views expressed herein are those of the authors and do not necessarily represent or reflect the views, policies or actions of the American Society of Anesthesiologists.

NL Archives

Information for Authors